We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current RGS market cap is 3.68M. The company's latest EPS is AUD -0.0074 and P/E is -56.76.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 1.66M | 7.07M | 0 | 0 | 129k |
| Operating Income | -700k | 2.66M | -4.01M | -1.28M | -2.25M |
| Net Income | -894k | 2.76M | -4.31M | -1.69M | -2.26M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 4.79M | 8.51M | 2.56M | 2.46M | 5.65M |
| Total Liabilities | 3.7M | 4.37M | 1.48M | 2.59M | 2.87M |
| Total Equity | 1.09M | 4.15M | 1.08M | -125k | 2.78M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -1.92M | 2.42M | -3.59M | -660k | -156k |
| Investing | 16k | -8k | -8k | -48k | -416k |
| Financing | 2.63M | 400k | -98k | 916k | 3.13M |
| Market Cap | 3.68M |
| Price to Earnings Ratio | -56.76 |
| Price to Sales Ratio | 1.05k |
| Price to Cash Ratio | 45.16 |
| Price to Book Ratio | 46.36 |
| Dividend Yield | - |
| Shares Outstanding | 306.44M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 200.00% |
| 52 Week High | 0.016 |
| 52 Week Low | 0.004 |
| Spread (Intraday) | 0 (7.69%) |
| Company Name | Regeneus Ltd |
| Address |
16 goodhope street sydney, new south wales 2021 |
| Website | https://www.cambium.bio |
| Industry | veterinary svcs-animal specs (0742) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
